Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last 20 years and is expected to increase until 2030 in some countries includ
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| In: |
Annals of oncology
Year: 2018, Jahrgang: 29, Pages: iv238-iv255 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdy308 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdy308
|
| Verfasserangaben: | A. Vogel, A. Cervantes, I. Chau, B. Daniele, J.M. Llovet, T. Meyer, J.-C. Nault, U. Neumann, J. Ricke, B. Sangro, P. Schirmacher, C. Verslype, C.J. Zech, D. Arnold & E. Martinelli, on behalf of the ESMO Guidelines Committee |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662378645 | ||
| 003 | DE-627 | ||
| 005 | 20220816121338.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190326s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdy308 |2 doi | |
| 035 | |a (DE-627)1662378645 | ||
| 035 | |a (DE-599)KXP1662378645 | ||
| 035 | |a (OCoLC)1341205589 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Vogel, Arndt |d 1971- |e VerfasserIn |0 (DE-588)12366960X |0 (DE-627)082697256 |0 (DE-576)293818622 |4 aut | |
| 245 | 1 | 0 | |a Hepatocellular carcinoma |b ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |c A. Vogel, A. Cervantes, I. Chau, B. Daniele, J.M. Llovet, T. Meyer, J.-C. Nault, U. Neumann, J. Ricke, B. Sangro, P. Schirmacher, C. Verslype, C.J. Zech, D. Arnold & E. Martinelli, on behalf of the ESMO Guidelines Committee |
| 264 | 1 | |c 2018 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.03.2019 | ||
| 520 | |a The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last 20 years and is expected to increase until 2030 in some countries includ | ||
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 29(2018), Supplement 4, Seite iv238-iv255 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Hepatocellular carcinoma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| 773 | 1 | 8 | |g volume:29 |g year:2018 |g supplement:Supplement 4 |g pages:iv238-iv255 |g extent:18 |a Hepatocellular carcinoma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| 787 | 0 | 8 | |i Ergänzung |a Vogel, Arndt, 1971 - |t Corrigendum to “Hepatocellular carcinoma |d 2022 |w (DE-627)1811125573 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdy308 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190326 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 11 | ||
| 999 | |a KXP-PPN1662378645 |e 3416298691 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["A. Vogel, A. Cervantes, I. Chau, B. Daniele, J.M. Llovet, T. Meyer, J.-C. Nault, U. Neumann, J. Ricke, B. Sangro, P. Schirmacher, C. Verslype, C.J. Zech, D. Arnold & E. Martinelli, on behalf of the ESMO Guidelines Committee"]},"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"note":["Gesehen am 26.03.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European Society for Medical Oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1990 -"],"origin":[{"dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedDisp":"1990-"}],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"part":{"extent":"18","text":"29(2018), Supplement 4, Seite iv238-iv255","volume":"29","year":"2018","pages":"iv238-iv255"},"language":["eng"],"disp":"Hepatocellular carcinoma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology","id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"recId":"320428796"}],"physDesc":[{"extent":"18 S."}],"title":[{"title":"Hepatocellular carcinoma","subtitle":"ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","title_sort":"Hepatocellular carcinoma"}],"language":["eng"],"id":{"doi":["10.1093/annonc/mdy308"],"eki":["1662378645"]},"person":[{"role":"aut","family":"Vogel","display":"Vogel, Arndt","given":"Arndt","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","given":"Peter","display":"Schirmacher, Peter","family":"Schirmacher","role":"aut"}],"recId":"1662378645"} | ||
| SRT | |a VOGELARNDTHEPATOCELL2018 | ||